Faster testing & better insights for safer radiopharmaceutical therapies
Quality assurance with results in minutes, not hours – delivering comprehensive insights that improve patient safety and treatment outcomes.
Supported by
Comprehensive analysis in one scan
Other devices provide visibility only on alpha, beta, or gamma radiation, while Lyla offers full insight into the radiopharmaceutical's complete composition.
Lab-friendly and safe operation
Unlike other devices, which often require separate detectors and a fume hood, Lyla captures radiation in a sealed cartridge, reducing contamination risks and improving lab safety.
Free up valuable lab space
With a compact design and integrated functionality, this system eliminates the need for multiple devices and a fume hood, maximizing lab space and streamlining operations.
Lab work just got easier
Lab work shouldn't be complicated. We've designed Lyla to simplify your workflow, delivering accurate results with less effort.
Lyla TLC Scanner
Device for radiopharmaceutical quality assurance.
Encapsulated TLC sample in a cartridge for safe and efficient lab use.
Initially validated for Actinium-225.
Measures and quantifies alpha, beta, and gamma radiation energy spectra.
Lyla Quality Suite
Device for radiopharmaceutical quality assurance.
Encapsulated TLC sample in a cartridge for safe and efficient lab use.
Initially validated for Actinium-225.
Measures and quantifies alpha, beta, and gamma radiation energy spectra.
In the news
Lyla (previously Alphapace) proudly won the Philips Innovation Award 2024 in the Rough Diamond category, selected from 175 entries. This recognition highlights our innovative contribution to advancing healthcare and radiopharmaceutical quality testing.
Lyla (previously Alphapace) is honored to have received the Life Science Award, sponsored by BioPartner Leiden and Gulliver, recognizing our groundbreaking work in radiopharmaceuticals and our commitment to driving progress in this vital field.
